Follow
Aaron Lampano
Aaron Lampano
Verified email at umassmed.edu
Title
Cited by
Cited by
Year
Function of C/EBPδ in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals
V Litvak, SA Ramsey, AG Rust, DE Zak, KA Kennedy, AE Lampano, ...
Nature immunology 10 (4), 437-443, 2009
3312009
Cutting edge: Tlr5−/− mice are more susceptible to Escherichia coli urinary tract infection
E Andersen-Nissen, TR Hawn, KD Smith, A Nachman, AE Lampano, ...
The Journal of immunology 178 (8), 4717-4720, 2007
2502007
Methyl-CpG binding protein 2 regulates microglia and macrophage gene expression in response to inflammatory stimuli
JC Cronk, NC Derecki, E Ji, Y Xu, AE Lampano, I Smirnov, W Baker, ...
Immunity 42 (4), 679-691, 2015
1922015
A FOXO3–IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses
V Litvak, AV Ratushny, AE Lampano, F Schmitz, AC Huang, A Raman, ...
Nature 490 (7420), 421-425, 2012
1682012
Genome-wide histone acetylation data improve prediction of mammalian transcription factor binding sites
SA Ramsey, TA Knijnenburg, KA Kennedy, DE Zak, M Gilchrist, ES Gold, ...
Bioinformatics 26 (17), 2071-2075, 2010
902010
Role of the transcription factor C/EBPδ in a regulatory circuit that discriminates between transient and persistent Toll-like receptor 4-induced signals
V Litvak, SA Ramsey, AG Rust, DE Zak, KA Kennedy, AE Lampano, ...
Nature immunology 10 (4), 437, 2009
72009
Sirtuin 6 is required for the integrated stress response and resistance to inhibition of transcriptional cyclin-dependent kinases
N Kartha, JE Gianopulos, Z Schrank, SM Cavender, S Dobersch, ...
Science translational medicine 15 (694), eabn9674, 2023
32023
Development of a Novel, Allogeneic GPRC5D-Directed CAR for Treatment of Multiple Myeloma Patients
J Kinder, CA Estrada, B Granger, A O'Rourke, O Liang, A Lampano, ...
Blood 142, 3290, 2023
2023
Preclinical Efficacy of a Novel CD8-Targeted Fusosome for In Vivo CAR T Cell Therapy
V Chaturvedi, J Green, G Zipp, A Lampano, O Liang, A O'Rourke, ...
Blood 142, 7121, 2023
2023
Identification of Healthy Donor Phenotypic and Functional Signatures That Predict Allogeneic, Hypoimmune CD19-Directed CAR T Cell Potency
D Salloum, K Tundwal, KB Choi, A Ranere, J Lock, B Lam, J Kristianto, ...
Blood 142 (Supplement 1), 6810-6810, 2023
2023
Modulation of resting T cell status to enhance transduction and CAR T expansion following exposure to CD8-targeted fusosomes
B Dolinski, V Chaturvedi, D Humes, C Proano, M Ott, J Moreno, G Zipp, ...
Cancer Research 83 (7_Supplement), 2734-2734, 2023
2023
Development of a novel, fully human anti-CD19 chimeric antigen receptor for in vivo delivery via CD8-targeted fusosome
JM Kinder, C Ciarlo, CA Estrada, N van Hoeven, V Chaturvedi, G Zipp, ...
Cancer Research 83 (7_Supplement), 2735-2735, 2023
2023
BCMA-Targeted, Hypoimmune Allogeneic CAR T Cells Exhibit Potent Anti-Tumor Activity Together with the Ability to Evade Innate and Adaptive Immune Rejection in Pre-Clinical …
JM Kinder, C Athena-Estrada, D Malik, X Hu, M Lamba, C Young, ...
Blood 140 (Supplement 1), 7120-7121, 2022
2022
Sirtuin 6 histone deacetylase is required for the integrated stress response and resistance to inhibition of transcriptional cyclin dependent kinases in Pancreatic Ductal …
J Gianopulos, N Kartha, Z Schrank, S Dobersch, S Cavender, B Kynnap, ...
CANCER RESEARCH 82 (22), 107-108, 2022
2022
Abstract B075: Sirtuin 6 histone deacetylase is required for the integrated stress response and resistance to inhibition of transcriptional cyclin dependent kinases in …
J Gianopulos, N Kartha, Z Schrank, S Dobersch, S Cavender, B Kynnap, ...
Cancer Research 82 (22_Supplement), B075-B075, 2022
2022
Genome-wide histone acetylation data improve prediction of mammalian transcription factor binding sites Supplementary Material
SA Ramsey, TA Knijnenburg, KA Kennedy, DE Zak, M Gilchrist, ES Gold, ...
2011
Susceptible to
S Akira, A Aderem, A Nachman, AE Lampano, S Uematsu, ...
Journal of Immunology 178, 4717-4720, 2007
2007
The system can't perform the operation now. Try again later.
Articles 1–17